Suppressor of cytokine signaling 3 expression is diminished in sinonasal tissues from patients with chronic rhinosinusitis with nasal polyps

Kathryn E. Hulse; Katrina Chaung; Sudarshan Seshadri; Lydia Suh; James E. Norton; Roderick G. Carter; Robert C. Kern; David B. Conley; Rakesh K. Chandra; Bruce K. Tan; Anju T. Peters; Leslie C. Grammer; Kathleen E. Harris; Troy R. Torgerson; Atsushi Kato; Robert P. Schleimer

doi:10.1016/j.jaci.2013.08.015

Suppressor of cytokine signaling 3 expression is diminished in sinonasal tissues from patients with chronic rhinosinusitis with nasal polyps

Kathryn E. Hulse, Katrina Chaung, Sudarshan Seshadri, Lydia Suh, James E. Norton, Roderick G. Carter, Robert C. Kern, David B. Conley, Rakesh K. Chandra, Bruce K. Tan, Anju T. Peters, Leslie C. Grammer, Kathleen E. Harris, Troy R. Torgerson, Atsushi Kato, Robert P. Schleimer

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Original language	English (US)
Pages (from-to)	275-277.e1
Journal	Journal of Allergy and Clinical Immunology
Volume	133
Issue number	1
DOIs	https://doi.org/10.1016/j.jaci.2013.08.015
State	Published - Jan 2014

Funding

Disclosure of potential conflict of interest: R. P. Schleimer has consultant arrangements with Interesect ENT, GlaxoSmithKline, Allakos, and Aurasense. L. C. Grammer has received grants and travel support for meetings or other purposes from the National Institutes of Health (NIH) ; has received grants from the Bazley Foundation ; has consultant arrangements with Atellas Pharmaceuticals; is employed by Northwestern University and the Northwestern Medical Faculty Foundation; has grants/grants pending with the NIH , the Food Allergy Network , and S&C Electric ; has received payment for lectures, including service on speakers' bureaus, from the American Academy of Allergy, Asthma & Immunology and Mount Sinai; and receives royalties from Lippincott , UpToDate , BMJ , and Elsevier . B. K. Tan has received grants from the NIH and the Triological Society/American College of Surgeons ; has consultant arrangements with Acclarent, Inc, and has received travel/accommodations/meeting expenses from the Foundation for Innovation, Education, and Research in Otorhinolaryngology. T. R. Torgerson has consultant arrangements with Baxter Biosciences and BD Biosciences; has grants/grants pending with Baxter Biosciences and CSL Behring ; has received payment for lectures, including service on speakers' bureaus, from Baxter Biosciences; receives royalties from New England Biolabs ; and receives payment for the development of educational presentations from Baxter Biosciences. K. E. Harris has received grants from the NIH/National Heart, Lung and Blood Institute (grant no. R37L068546 and grant no. R01HL078860 ), the NIH/National Institute for Allergy and Infectious Disease (grant no. T32A1083216 ), and the Ernest S. Bazley Trust . A. T. Peters has received payment for lectures, including service on speakers' bureaus, from Baxter. A. Kato has received a grant from the NIH (grant no. R21HL113913 ). The rest of the authors declare that they have no relevant conflicts of interest. This study was funded by National Institutes of Health grants R37 HL068546 , R01 HL078860 , R01 AI072570 , and T32 AI083216 and the Ernest S. Bazley Trust .

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1016/j.jaci.2013.08.015

Cite this

Hulse, K. E., Chaung, K., Seshadri, S., Suh, L., Norton, J. E., Carter, R. G., Kern, R. C., Conley, D. B., Chandra, R. K., Tan, B. K., Peters, A. T., Grammer, L. C., Harris, K. E., Torgerson, T. R., Kato, A., & Schleimer, R. P. (2014). Suppressor of cytokine signaling 3 expression is diminished in sinonasal tissues from patients with chronic rhinosinusitis with nasal polyps. Journal of Allergy and Clinical Immunology, 133(1), 275-277.e1. https://doi.org/10.1016/j.jaci.2013.08.015

@article{44531eb1114b4485b39b6871c8849b24,

title = "Suppressor of cytokine signaling 3 expression is diminished in sinonasal tissues from patients with chronic rhinosinusitis with nasal polyps",

author = "Hulse, {Kathryn E.} and Katrina Chaung and Sudarshan Seshadri and Lydia Suh and Norton, {James E.} and Carter, {Roderick G.} and Kern, {Robert C.} and Conley, {David B.} and Chandra, {Rakesh K.} and Tan, {Bruce K.} and Peters, {Anju T.} and Grammer, {Leslie C.} and Harris, {Kathleen E.} and Torgerson, {Troy R.} and Atsushi Kato and Schleimer, {Robert P.}",

note = "Funding Information: Disclosure of potential conflict of interest: R. P. Schleimer has consultant arrangements with Interesect ENT, GlaxoSmithKline, Allakos, and Aurasense. L. C. Grammer has received grants and travel support for meetings or other purposes from the National Institutes of Health (NIH) ; has received grants from the Bazley Foundation ; has consultant arrangements with Atellas Pharmaceuticals; is employed by Northwestern University and the Northwestern Medical Faculty Foundation; has grants/grants pending with the NIH , the Food Allergy Network , and S&C Electric ; has received payment for lectures, including service on speakers' bureaus, from the American Academy of Allergy, Asthma & Immunology and Mount Sinai; and receives royalties from Lippincott , UpToDate , BMJ , and Elsevier . B. K. Tan has received grants from the NIH and the Triological Society/American College of Surgeons ; has consultant arrangements with Acclarent, Inc, and has received travel/accommodations/meeting expenses from the Foundation for Innovation, Education, and Research in Otorhinolaryngology. T. R. Torgerson has consultant arrangements with Baxter Biosciences and BD Biosciences; has grants/grants pending with Baxter Biosciences and CSL Behring ; has received payment for lectures, including service on speakers' bureaus, from Baxter Biosciences; receives royalties from New England Biolabs ; and receives payment for the development of educational presentations from Baxter Biosciences. K. E. Harris has received grants from the NIH/National Heart, Lung and Blood Institute (grant no. R37L068546 and grant no. R01HL078860 ), the NIH/National Institute for Allergy and Infectious Disease (grant no. T32A1083216 ), and the Ernest S. Bazley Trust . A. T. Peters has received payment for lectures, including service on speakers' bureaus, from Baxter. A. Kato has received a grant from the NIH (grant no. R21HL113913 ). The rest of the authors declare that they have no relevant conflicts of interest. Funding Information: This study was funded by National Institutes of Health grants R37 HL068546 , R01 HL078860 , R01 AI072570 , and T32 AI083216 and the Ernest S. Bazley Trust . ",

year = "2014",

month = jan,

doi = "10.1016/j.jaci.2013.08.015",

language = "English (US)",

volume = "133",

pages = "275--277.e1",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier Inc.",

number = "1",

}

Hulse, KE, Chaung, K, Seshadri, S, Suh, L, Norton, JE, Carter, RG, Kern, RC , Conley, DB, Chandra, RK, Tan, BK , Peters, AT , Grammer, LC, Harris, KE, Torgerson, TR, Kato, A & Schleimer, RP 2014, 'Suppressor of cytokine signaling 3 expression is diminished in sinonasal tissues from patients with chronic rhinosinusitis with nasal polyps', Journal of Allergy and Clinical Immunology, vol. 133, no. 1, pp. 275-277.e1. https://doi.org/10.1016/j.jaci.2013.08.015

TY - JOUR

T1 - Suppressor of cytokine signaling 3 expression is diminished in sinonasal tissues from patients with chronic rhinosinusitis with nasal polyps

AU - Hulse, Kathryn E.

AU - Chaung, Katrina

AU - Seshadri, Sudarshan

AU - Suh, Lydia

AU - Norton, James E.

AU - Carter, Roderick G.

AU - Kern, Robert C.

AU - Conley, David B.

AU - Chandra, Rakesh K.

AU - Tan, Bruce K.

AU - Peters, Anju T.

AU - Grammer, Leslie C.

AU - Harris, Kathleen E.

AU - Torgerson, Troy R.

AU - Kato, Atsushi

AU - Schleimer, Robert P.

N1 - Funding Information: Disclosure of potential conflict of interest: R. P. Schleimer has consultant arrangements with Interesect ENT, GlaxoSmithKline, Allakos, and Aurasense. L. C. Grammer has received grants and travel support for meetings or other purposes from the National Institutes of Health (NIH) ; has received grants from the Bazley Foundation ; has consultant arrangements with Atellas Pharmaceuticals; is employed by Northwestern University and the Northwestern Medical Faculty Foundation; has grants/grants pending with the NIH , the Food Allergy Network , and S&C Electric ; has received payment for lectures, including service on speakers' bureaus, from the American Academy of Allergy, Asthma & Immunology and Mount Sinai; and receives royalties from Lippincott , UpToDate , BMJ , and Elsevier . B. K. Tan has received grants from the NIH and the Triological Society/American College of Surgeons ; has consultant arrangements with Acclarent, Inc, and has received travel/accommodations/meeting expenses from the Foundation for Innovation, Education, and Research in Otorhinolaryngology. T. R. Torgerson has consultant arrangements with Baxter Biosciences and BD Biosciences; has grants/grants pending with Baxter Biosciences and CSL Behring ; has received payment for lectures, including service on speakers' bureaus, from Baxter Biosciences; receives royalties from New England Biolabs ; and receives payment for the development of educational presentations from Baxter Biosciences. K. E. Harris has received grants from the NIH/National Heart, Lung and Blood Institute (grant no. R37L068546 and grant no. R01HL078860 ), the NIH/National Institute for Allergy and Infectious Disease (grant no. T32A1083216 ), and the Ernest S. Bazley Trust . A. T. Peters has received payment for lectures, including service on speakers' bureaus, from Baxter. A. Kato has received a grant from the NIH (grant no. R21HL113913 ). The rest of the authors declare that they have no relevant conflicts of interest. Funding Information: This study was funded by National Institutes of Health grants R37 HL068546 , R01 HL078860 , R01 AI072570 , and T32 AI083216 and the Ernest S. Bazley Trust .

PY - 2014/1

Y1 - 2014/1

UR - http://www.scopus.com/inward/record.url?scp=84891738269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891738269&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2013.08.015

DO - 10.1016/j.jaci.2013.08.015

M3 - Article

C2 - 24084073

AN - SCOPUS:84891738269

SN - 0091-6749

VL - 133

SP - 275-277.e1

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 1

ER -

Suppressor of cytokine signaling 3 expression is diminished in sinonasal tissues from patients with chronic rhinosinusitis with nasal polyps

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this